1Saint Joseph University, Beirut, Lebanon

2Department of Obstetrics and Gynecology, Hôtel-Dieu de France University Hospital, Beirut, Lebanon

3Department of Plastic, Reconstructive and Maxillofacial Surgery, Hôtel-Dieu de France University Hospital, Beirut, Lebanon

4Surgery Department, Saint George Hospital University Medical Center, Beirut, Lebanon

5Department of Pathology, Hôtel-Dieu de France University Hospital, Beirut, Lebanon

6Department of Oncology, Hôtel-Dieu de France University Hospital, Beirut, Lebanon

Reprint requests to: David Atallah, MD, MSc, Saint Joseph University, Alfred Naccache Blvd, P.O.Box: 116-5137, Musee, Beirut, Lebanon. E-mail: [email protected]

The authors have declared they have no conflicts of interest.

No funding from Merck and Co, Inc, was offered. Likewise, there is no professional link between the investigators and the Merck and Co, team, Inc, on the subject of human papillomavirus or vaccination.

The study was approved by the ethics committee of the Saint-Joseph University of Beirut, Lebanon (CEHDF 946, April 6, 2017).

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.jlgtd.com).